Characteristic | Persisitent smokers (Nā=ā172) | Never smokers (Nā=ā351) | Quitters (Nā=ā126) | P Value | |||
---|---|---|---|---|---|---|---|
3 Groups | Persistent vs Never | Persistent vs Quitter | Never vs Quitter | ||||
Age (years) | 60.27āĀ±ā9.65 | 65.05āĀ±ā9.32 | 60.21āĀ±ā9.12 | <0.001 | <0.001 | 0.956 | <0.001 |
Male n (%) | 155 (90.1) | 211 (60.1) | 118 (93.7) | <0.001 | <0.001 | 0.277 | <0.001 |
Marital status n (%) | 147 (85.5) | 310 (88.3) | 114 (90.5) | 0.405 | 0.356 | 0.195 | 0.509 |
Body mass index (kg/m2) | 25.79āĀ±ā2.80 | 25.12āĀ±ā2.91 | 25.91āĀ±ā2.74 | 0.005 | 0.011 | 0.739 | 0.008 |
Risk Factors n (%) | |||||||
āDiabetes mellitus | 33 (16.9) | 89 (25.4) | 19 (15.1) | 0.015 | 0.029 | 0.679 | 0.021 |
āHypertension | 105 (61.0) | 244 (69.5) | 81 (64.3) | 0.003 | 0.002 | 0.718 | 0.019 |
āHypercholesterolemia | 55 (32) | 126 (35.9) | 44 (34.9) | 0.674 | 0.376 | 0.594 | 0.844 |
āHeart failure | 16 (9.3) | 25 (7.12) | 11 (8.73) | 0.808 | 0.529 | 0.865 | 0.712 |
āImpaired renal dysfunction | 6 (3.5) | 15 (4.3) | 4 (3.2) | 0.858 | 0.667 | 0.882 | 0.588 |
āPrior AMI n (%) | 30 (17.4) | 36 (10.3) | 23 (18.3) | 0.021 | 0.020 | 0.856 | 0.019 |
āUnstable angina | 117 (68.0) | 221 (63.0) | 82 (65.1) | 0.521 | 0.225 | 0.594 | 0.672 |
Left ventricular ejection fraction | 65.52āĀ±ā6.93 | 65.38āĀ±ā8.84 | 66.28āĀ±ā8.43 | 0.577 | 0.86 | 0.435 | 0.299 |
In-hospital laboratory test | |||||||
āFasting plasma glucose (mmol/L) | 5.48āĀ±ā1.55 | 5.77āĀ±ā1.34 | 5.51āĀ±ā1.26 | 0.170 | 0.125 | 0.477 | 0.229 |
āTotal cholesterol (mmol/L) | 4.07āĀ±ā0.88 | 4.21āĀ±ā1.35 | 4.16āĀ±ā0.87 | 0.422 | 0.190 | 0.522 | 0.651 |
āTriglycerides (mmol/L) | 1.67āĀ±ā0.93 | 1.58āĀ±ā1.15 | 1.75āĀ±ā1.13 | 0.308 | 0.393 | 0.532 | 0.141 |
āHDL cholesterol (mmol/L) | 0.96āĀ±ā0.19 | 0.99āĀ±ā0.20 | 0.98āĀ±ā0.14 | 0.136 | 0.046 | 0.319 | 0.505 |
āLDL cholesterol (mmol/L) | 2.43āĀ±ā0.77 | 2.31āĀ±ā0.82 | 2.44āĀ±ā0.78 | 0.122 | 0.085 | 0.974 | 0.114 |
In-hospital treatments n (%) | |||||||
āAntiplatalet | 172 (100) | 351 (100) | 126 (100) | 1.000 | 1.000 | 1.000 | 1.000 |
āStatins | 169 (98.3) | 348 (99.1) | 123 (97.6) | 0.441 | 0.370 | 0.699 | 0.187 |
āACEI/ARB | 110 (64.0) | 215 (61.3) | 82 (65.1) | 0.693 | 0.550 | 0.841 | 0.447 |
āCCB | 31 (18.0) | 74 (21.1) | 26 (20.6) | 0.708 | 0.412 | 0.571 | 0.916 |
āĪ²-blockers | 87 (50.6) | 190 (54.1) | 66 (52.4) | 0.742 | 0.445 | 0.759 | 0.735 |
No. of diseased vessels n (%) | Ā | Ā | Ā | 0.429 | 0.185 | 0.892 | 0.528 |
ā1 | 85 (49.4) | 158 (45.0) | 61 (48.4) | Ā | Ā | Ā | Ā |
ā2 | 50 (29.1) | 91 (25.9) | 35 (27.8) | Ā | Ā | Ā | Ā |
ā3 | 37 (21.5) | 102 (29.1) | 30 (23.8) | Ā | Ā | Ā | Ā |
Reference vessel diameter (mm) | 2.95āĀ±ā0.42 | 3.01āĀ±ā0.40 | 2.96āĀ±ā0.34 | 0.213 | 0.100 | 0.732 | 0.277 |
Percentage diameter stenosis (%) | 85.82āĀ±ā12.31 | 84.61āĀ±ā11.22 | 86.86āĀ±ā11.55 | 0.146 | 0.260 | 0.446 | 0.062 |
B2/C class lesion n, (%) | 129 (75.0) | 253 (72.1) | 99 (78.6) | 0.344 | 0.480 | 0.472 | 0.155 |
Predilation n,(%) | 148 (86.0) | 299 (85.2) | 111 (88.1) | 0.722 | 0.793 | 0.604 | 0.420 |
Stent diameter (mm) | 3.02āĀ±ā0.41 | 3.08āĀ±ā0.39 | 3.02āĀ±ā0.34 | 0.104 | 0.074 | 0.982 | 0.104 |
Total stent length (mm) | 32.18āĀ±ā6.53 | 32.36āĀ±ā7.00 | 33.56āĀ±ā6.57 | 0.431 | 0.196 | 0.439 | 0.775 |
Stent delivery pressure (atm) | 14.50āĀ±ā2.31 | 14.39āĀ±ā2.26 | 14.68āĀ±ā2.05 | 0.435 | 0.583 | 0.487 | 0.202 |
Postdilation n,(%) | 57 (33.1) | 106 (30.2) | 45 (35.7) | 0.491 | 0.495 | 0.644 | 0.254 |